Form D · Hedge Fund

GAMCO MEDICAL OPPORTUNITIES, L.P.

Greenwich, CT · CIK 0001456987

Offering snapshot reported Nov 28, 2025 · SEC filing

Reported sold
$15.7M
Indefinite offering
Investors reported
32
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 1, 2006
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.84M$15.7MMar 16, 2009: $7,200,000.00Mar 16, 2009Jan 20, 2010: $7,200,000.00Jan 21, 2011: $7,300,000.00Jan 13, 2012: $7,600,000.00Jan 14, 2013: $7,600,000.00Jan 15, 2014: $9,901,798.00Jan 15, 2015: $9,901,798.00Jan 15, 2016: $11,902,757.00Dec 28, 2016: $12,002,757.00Dec 28, 2017: $12,002,757.00Dec 28, 2018: $12,002,757.00Dec 27, 2019: $12,002,757.00Dec 16, 2020: $12,002,757.00Dec 16, 2021: $15,682,116.00Dec 2, 2022: $15,682,116.00Dec 1, 2023: $15,682,116.00Nov 29, 2024: $15,682,116.00Nov 28, 2025: $15,682,116.00Nov 28, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 28, 2025Amendment$15,682,116$0vs Nov 29, 202432SEC filing
Nov 29, 2024Amendment$15,682,116$0vs Dec 1, 202332SEC filing
Dec 1, 2023Amendment$15,682,116$0vs Dec 2, 202232SEC filing
Dec 2, 2022Amendment$15,682,116$0vs Dec 16, 202132SEC filing
Dec 16, 2021Amendment$15,682,116$3,679,359vs Dec 16, 202032SEC filing
Dec 16, 2020Amendment$12,002,757$0vs Dec 27, 201931SEC filing
Dec 27, 2019Amendment$12,002,757$0vs Dec 28, 201831SEC filing
Dec 28, 2018Amendment$12,002,757$0vs Dec 28, 201730SEC filing
Dec 28, 2017Amendment$12,002,757$0vs Dec 28, 201630SEC filing
Dec 28, 2016Amendment$12,002,757$100,000vs Jan 15, 201630SEC filing
Jan 15, 2016Amendment$11,902,757$2,000,959vs Jan 15, 201530SEC filing
Jan 15, 2015Amendment$9,901,798$0vs Jan 15, 201425SEC filing
Jan 15, 2014Amendment$9,901,798$2,701,798vs Mar 16, 200925SEC filing
Jan 14, 2013Amendment$7,600,000$400,000vs Mar 16, 200924SEC filing
Jan 13, 2012Amendment$7,600,000$400,000vs Mar 16, 200924SEC filing
Jan 21, 2011Amendment$7,300,000$100,000vs Mar 16, 200924SEC filing
Jan 20, 2010Amendment$7,200,000$0vs Mar 16, 200924SEC filing
Mar 16, 2009Initial$7,200,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-127925
If applicable, employees of the recipient listed in item 12. are paid an amount equal to a percentage of the management fee paid to the Investment Manager (or its affiliate) attributable to certain assets under management.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
G.research, LLC000007353

Source: Form D, filed Nov 28, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

GAMCO MEDICAL OPPORTUNITIES, LP

Investment adviser: GABELLI & COMPANY INVESTMENT ADVISERS, INC.

Gross asset value
$7.32M
Beneficial owners
11
ADV minimum commitment
$1M

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator BNP PARIBAS FINANCIAL SERVICES, LLC KING OF PRUSSIA, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS GRAND CAYMAN, Cayman Islands
Custodian UBS SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Marketer ARETE WEALTH MANAGEMENT, LLC CHICAGO, Illinois, United States Related to adviser: No
Marketer DELPHOS MMJ L.P. NEW YORK, New York, United States Related to adviser: No
Marketer NICOLO DUBINI MILANO, Italy Related to adviser: No
Marketer PAULLIER & CIA INTL. CORP. PANAMA, Panama Related to adviser: No
Marketer VICTOR PAULLIER & CIA MONTEVIDEO, Uruguay Related to adviser: No
Prime broker UBS SECURITIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS
PCAOB 1266

UBS SECURITIES LLC
SEC 8-22651

ARETE WEALTH MANAGEMENT, LLC
CRD 44856 · SEC 8-50854

DELPHOS MMJ L.P.
CRD 137389 · SEC 8-67083

UBS SECURITIES LLC
CRD 7654 · SEC 8-22651

Filing source

Form ADV 2118089 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-6717381959

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gabelli & Company Investment Advisers, Inc. Executive
Gabelli & Partners, Llc Executive
Gabelli Securities, Inc. Executive
Douglas R. Jamieson Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
191 Mason Street
Greenwich, CT, 06830